|Systematic (IUPAC) name|
|(what is this?)|
Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s. Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant. The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|